Generating Evidence. Transforming Lives

We envision a healthy and empowered population with access to evidence-based health services and solutions.

We’ll strive to achieve this vision by transforming into a center of excellence that informs health policies and delivery of quality services collaboratively through research, innovation, capacity strengthening and program implementation.

About IHI

Ifakara Health Institute (IHI) is a leading health research organization in Africa, with a strong track record of developing, testing and validating innovations for health. We are driven by core strategic mandate for research, training and services. Ifakara encompasses a broad range of scientific disciplines, spanning from basic biomedical and ecological sciences to clinical trials, health systems research, policy translation, and health program implementation.

Explore Who We Are

Our Projects

We have over sixty active projects.

Assessing impact of the 1,7-mRCTR reactive testing and response

The Study on the Policy Ecology of China-Africa Cooperation for Malaria Control and the Impact of 1,7-malaria Reactive Community Testing and Response (1,7-mRCTR) aims to assess the real-world impact of the 1,7-mRCTR strategy and to understand the context in which it …

Mpox Vaccine Phase II Trial - "BNT166-02 Study"

The BNT166-02 study is a Phase II clinical trial evaluating the safety, reactogenicity, and immunogenicity of BNT166a, a next-generation mRNA-based vaccine developed by BioNTech to prevent mpox (monkeypox). The study focuses on healthy individuals aged 12 years and a…

MTBVAC TB Vaccine Study

This project aims to evaluate the efficacy, safety, and immunogenicity of the MTBVAC vaccine candidate in preventing tuberculosis (TB) among adolescents and adults aged 14-45 years, living in TB-endemic regions.

More Projects